Finance

Lists
4534:TYO
Mochida Pharmaceutical Co Ltd
Â¥3,355.00
+0.15%
(+5.00) 1D
Nov 13, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4534...
Open
Â¥3,350
High
Â¥3,370
Low
Â¥3,330
Mkt. cap
122.09B
Avg. vol.
48.10K
Volume
26.50K
Dividend
2.46%
Quarterly dividend
Â¥21
Ex-dividend date
Sep 29, 2026
P/E ratio
11.03
52-wk high
Â¥3,965
52-wk low
Â¥3,070
EPS
Â¥304
Shares outstanding
19.85M
No. of employees
1K
Open
Â¥3,350
High
Â¥3,370
Low
Â¥3,330
Mkt. cap
122.09B
Avg. vol.
48.10K
Volume
26.50K
Dividend
2.46%
Quarterly dividend
Â¥21
Ex-dividend date
Sep 29, 2026
P/E ratio
11.03
52-wk high
Â¥3,965
52-wk low
Â¥3,070
EPS
Â¥304
Shares outstanding
19.85M
No. of employees
1K
News stories
From web sources and news partners
Profile
Mochida Pharmaceutical Co., Ltd is a Japanese pharmaceutical company. One of its products is the antidepressant setiptiline. Wikipedia
About Mochida Pharmaceutical Co Ltd
CEO-
Employees1.48K
FoundedApr 28, 1945
HeadquartersShinjuku City, Tokyo, Japan
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
32.50B
29.46B
31.72B
32.65B
Cost of goods sold
17.50B
15.06B
17.03B
17.24B
Cost of revenue
17.50B
15.06B
17.03B
17.24B
Research and development expenses
-
12.16B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.45B
-376.00M
11.12B
11.86B
Operating expense
12.45B
11.78B
11.12B
11.86B
Total operating expenses
29.94B
26.84B
28.15B
29.11B
Operating income
2.56B
2.62B
3.56B
3.54B
Other non operating income
-67.00M
12.00M
34.00M
32.00M
EBT including unusual items
3.17B
2.82B
4.86B
4.28B
EBT excluding unusual items
3.17B
2.85B
4.19B
3.94B
Income tax expense
681.00M
1.26B
1.69B
748.00M
Effective tax rate
21.50%
44.72%
34.68%
17.49%
Other operating expenses
-
-
-
-
Net income
2.49B
1.56B
3.18B
3.53B
Net profit margin
7.65%
5.30%
10.02%
10.81%
Earnings per share
-
-
-
-
Interest and investment income
232.00M
42.00M
297.00M
43.00M
Interest expense
-29.00M
-42.00M
-43.00M
-50.00M
Net interest expenses
203.00M
-
254.00M
-7.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
3.37B
4.31B
4.28B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps